Latest Interviews
Showing 1–2 of 2 transcripts.
Clear all filters- Milken Institute1h 15m
The Promise of the Bioscience Century
Paul Irving, Mike Milken, Eric Cantor, Paul Chu, Jeff, Bernardo Zavala, Jr., Bernard Harris, Andy von Eschenbach, Peggy, Francis Collins, Chris Austin
This event analyzes the critical role of bioscience in driving global economic growth and societal well-being while highlighting China's aggressive $308 billion investment program that threatens to surpass U.S. leadership. Panelists discuss strategic institutional responses, such as DARPA's high-risk research model and the FDA's regulatory innovations, which have accelerated breakthroughs in prosthetics, personalized medicine, and disease prevention. However, fiscal constraints and shifting global demographics necessitate sustained bipartisan funding to preserve the United States' status as a central hub for scientific innovation and global health security.
- Milken Institute7 min
The Global Biomedical Industry: Preserving U.S. Leadership
The Milken Institute's latest report highlights the critical role of the U.S. biomedical sector, which supports over 5 million jobs but faces declining competitiveness due to outdated tax structures and shrinking domestic STEM enrollment. With the era of blockbuster drugs ending and rivals like China rapidly advancing in nanotechnology, the study argues that immediate policy reforms are essential to restore American leadership. Key recommendations include permanently enhancing the R&D tax credit by 25%, reducing the federal corporate tax rate to the advanced economy average of 23%, and increasing funding for the FDA and NIH to better accommodate personalized medicine frameworks.